Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UBT251 Dose-finding Study in Type 2 Diabetes
NCT07668388Phase 2Recruiting
- Sponsor
- Novo Nordisk
- Start
- Jun 2026
- Primary completion
- Oct 2027
- Countries
- 9
01
Overview
A Phase 2 trial of UBT251 in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jun 2026; status: recruiting.
02
Drugs
UBT251
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07668388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668388.